Chlorogenic acid attenuates cyclophosphamide-induced rat interstitial cystitis
- Life Sci. 2020 Aug 1;254:117590. doi: 10.1016/j.lfs.2020.117590.
- 1. Department of Urology, Second Affiliated Hospital, Army Military Medical University, Chongqing, People's Republic of China.
- 2. Department of Urology, Second Affiliated Hospital, Army Military Medical University, Chongqing, People's Republic of China. Electronic address: [email protected].
Aims: This study aimed to investigate the therapeutic effect and molecular mechanism of chlorogenic acid (CGA) on cyclophosphamide (CYP)-induced rat interstitial cystitis (IC).
Materials and methods: An animal model of IC was established by intraperitoneal injection of CYP in female Sprague-Dawley rats. Eighty rats were randomly assigned to four groups: negative control (NC), NC treated with CGA (NC + CGA), IC, and IC treated with CGA (IC + CGA). Bladder urination function was assessed by analyzing urodynamic parameters. The expression of apoptosis-related proteins and inflammatory biomarkers in bladder specimens was detected using western blot and immunohistochemistry analysis.
Key findings: Compared with the IC group, bladder urinary function was significantly improved in the IC + CGA group. CGA treatment reduced inflammatory damage in the bladder tissue of IC rats. Caspase3 and Bax expression was higher while Bcl-2 expression was lower in the IC group compared to the IC + CGA group. In addition, there were significant differences between the groups in the expression levels of inflammatory biomarkers in the bladder tissue. Furthermore, CGA could inhibit CYP-induced MAPK/NF-κB phosphorylation in the rat bladder tissue.
Significance: In a CYP-induced rat model of IC, CGA could reduce inflammation and Apoptosis, thus partially restoring bladder function, and the MAPK/NF-κB pathway was probably involved in it.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: DNA Alkylator/CrosslinkerResearch Areas: Cancer
-